These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study. Chakrabarti S, Collingham KE, Holder K, Fegan CD, Osman H, Milligan DW. Bone Marrow Transplant; 2001 Oct; 28(8):759-63. PubMed ID: 11781627 [Abstract] [Full Text] [Related]
9. Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation. Stamouli M, Tsonis I, Gkirkas K, Economopoulou C, Siafakas N, Pournaras S, Antoniadou A, Chondropoulos S, Karagiannidi A, Meletiadis J, Gigantes S, Baltadakis I, Goussetis E, Karakasis D, Tsirigotis P. Bone Marrow Transplant; 2021 Feb; 56(2):511-513. PubMed ID: 32772044 [No Abstract] [Full Text] [Related]
19. Upper respiratory viral infections in patients with haematological malignancies after allogeneic haematopoietic stem cell transplantation: a retrospective study. Atilla E, Sahin D, Atilla PA, Dolapci I, Tekeli A, Bozdag SC, Yuksel MK, Toprak SK, Ilhan O, Arslan O, Ozcan M, Gurman G, Topcuoglu P. Antivir Ther; 2018 Nov; 23(6):523-527. PubMed ID: 29424696 [Abstract] [Full Text] [Related]
20. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin. McCurdy LH, Milstone A, Dummer S. J Heart Lung Transplant; 2003 Jul; 22(7):745-53. PubMed ID: 12873542 [Abstract] [Full Text] [Related] Page: [Next] [New Search]